The Patent Finder

Maintenance fees coming due

Beone Medicines I GmbH

25 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Dec 13, 2026. Unpaid by Jun 14, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,673,951ANTI-PD1 Antibodies and Their Use as Therapeutics and Diagnostics
In force
Fee due Dec 13, 2026
Lapses if unpaid Jun 14, 2027
 · Low confidence
Beone Medicines I GmbHIn forceDec 13, 2026Jun 14, 2027Low confidence
US 10,351,559Maleate Salts of a B-Raf Kinase Inhibitor, Crystalline Forms, Methods of Preparation, and Uses Therefore
In force
Fee due Jan 16, 2027
Lapses if unpaid Jul 16, 2027
 · High confidence
Beone Medicines I GmbHIn forceJan 16, 2027Jul 16, 2027High confidence
US 11,701,357Treatment of B Cell Cancers Using a Combination Comprising BTK Inhibitors and Obinutuzumab
In force
Fee due Jan 18, 2027
Lapses if unpaid Jul 19, 2027
 · High confidence
Beone Medicines I GmbHIn forceJan 18, 2027Jul 19, 2027High confidence
US 11,725,012IMIDAZO[1,5-a]PYRAZINE DERIVATIVES AS PI3K DELTA INHIBITORS
In force
Fee due Feb 15, 2027
Lapses if unpaid Aug 16, 2027
 · High confidence
Beone Medicines I GmbHIn forceFeb 15, 2027Aug 16, 2027High confidence
US 11,786,529Treatment of Indolent or Aggressive B-Cell Lymphomas Using a Combination Comprising BTK Inhibitors
In force
Fee due Apr 17, 2027
Lapses if unpaid Oct 18, 2027
 · High confidence
Beone Medicines I GmbHIn forceApr 17, 2027Oct 18, 2027High confidence
US 11,786,531Methods of Treating B-Cell Proliferative Disorder
In force
Fee due Apr 17, 2027
Lapses if unpaid Oct 18, 2027
 · High confidence
Beone Medicines I GmbHIn forceApr 17, 2027Oct 18, 2027High confidence
US 10,457,680Process for Preparing a Parp Inhibitor, Crystalline Forms, and Uses Thereof
In force
Fee due Apr 29, 2027
Lapses if unpaid Oct 29, 2027
 · High confidence
Beone Medicines I GmbHIn forceApr 29, 2027Oct 29, 2027High confidence
US 11,814,389CRYSTALLINE FORM OF (S)-7-(1-Acryloylpiperidin-4-YL)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-Carboxamide, PREPARATION, AND USES THEREOF
In force
Fee due May 14, 2027
Lapses if unpaid Nov 15, 2027
 · High confidence
Beone Medicines I GmbHIn forceMay 14, 2027Nov 15, 2027High confidence
US 10,501,467Fused Tetra or Penta-Cyclic Dihydrodiazepinocarbazolones as Parp Inhibitors
In force
Fee due Jun 10, 2027
Lapses if unpaid Dec 10, 2027
 · High confidence
Beone Medicines I GmbHIn forceJun 10, 2027Dec 10, 2027High confidence
US 9,217,034ANTI-PD1 Antibodies and Their Use as Therapeutics and Diagnostics
In force
Fee due Jun 22, 2027
Lapses if unpaid Dec 22, 2027
 · Medium confidence
Beone Medicines I GmbHIn forceJun 22, 2027Dec 22, 2027Medium confidence
15 more maintenance fees coming due in the 12 months from Nov 21, 2026 · Pro
10 of 25 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited